Panacea Biotec gets nod for allotment of NCDs worth Rs 743 crore

09 Apr 2019 Evaluate

Panacea Biotec has received an approval for the allotment of 74,300 unrated, unlisted, redeemable, non-convertible debentures (NCDs), having the face value of Rs 1 lakh each, aggregating to Rs 743 crore on private placement basis. The Executive Committee of the Board of Directors of the Company at its meeting held on April 08, 2019, approved the same.


Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities. It is one of the largest vaccine producers and biotechnology companies in India.

Panacea Biotec Share Price

364.20 -4.40 (-1.19%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×